Eli Lilly And Company

This early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated early, so results are limited.

This phase 2b study tested the drug peresolimab in 491 adults with moderately-to-severely active rheumatoid arthritis who had not responded well to other treatments. The goal was to see if peresolimab could reduce joint pain and swelling better than a placebo. However, the trial …

This study tested an experimental drug called LY3541860 in 35 adults with moderate-to-severe rheumatoid arthritis who had not improved enough on other treatments. The goal was to see if the drug could reduce joint swelling and pain. However, the trial was terminated early, so the…

This study tested the drug baricitinib in children aged 1 to 18 who were hospitalized with COVID-19 and needed extra oxygen. The goal was to see if the drug was safe and how it worked in kids. Only 6 children took part before the study was stopped early.

This study tested a new medicine called LY3454738 in adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it could improve skin symptoms like redness and itching. The trial included 234 participants and was stopped early. Results may help understand i…

This early-phase study tested a new drug called LY3127804, given alone or with another drug (ramucirumab), in 62 people with advanced solid tumors. The main goal was to check safety and find the right dose. The study was stopped early, and the highest safe dose could not be deter…

This early-stage study tested a new drug called LY3405105 in 54 people with advanced solid tumors. The main goal was to check the drug's safety and find the right dose. The study was stopped early, so results are limited.

This study tested an investigational drug called LY3540378 in 332 adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly (HFpEF). The goal was to see if the drug could improve heart function and safety compared to a placebo. The trial…

This study aimed to see if lasmiditan, a migraine medicine, is safe and works for children aged 6 to 17. It planned to treat migraine attacks and measure pain relief. The trial was stopped early, so final results are limited, but it may still provide useful information about trea…

This study tested the safety and effectiveness of lasmiditan, a migraine medication, in children aged 6 to 17. Over 12 months, researchers tracked side effects and how well the drug relieved migraine pain within 2 hours. The trial was stopped early, but the results help understan…

This early-phase study aimed to test the safety of a new drug called LY3872386 in healthy volunteers and people with atopic dermatitis (eczema). The trial was terminated early, so no meaningful data on safety or how the body processes the drug were collected. Only 18 participants…

This early-stage study tested the safety and side effects of an experimental drug called LY3463251 in healthy and overweight adults. Participants received either the drug or a placebo as a single or multiple injection under the skin. The study was stopped early, and it was not de…

This study tested the safety and side effects of an experimental drug called LY3526318 in 76 healthy adults. Participants took the drug by mouth in either a single dose or multiple doses over several days. The goal was to see how the body processes the drug and whether it causes …